Maynard Charles, Longstreth W T, Nichol Graham, Hallstrom Al, Kudenchuk Peter J, Rea Thomas, Copass Michael K, Carlbom David, Deem Steven, Olsufka Michele, Cobb Leonard A, Kim Francis
Department of Health Services, School of Public Health, University of Washington, Seattle, WA (C.M.).
Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA (L.) Department of Neurology, School of Medicine, University of Washington, Seattle, WA (L., M.K.C.).
J Am Heart Assoc. 2015 Mar 11;4(3):e001693. doi: 10.1161/JAHA.114.001693.
Randomized trials of prehospital cooling after cardiac arrest have shown that neither prehospital cooling nor targeted temperature management differentially affected short-term survival or neurological function. In this follow-up study, we assess the association of prehospital hypothermia with neurological function at least 3 months after cardiac arrest and survival 1 year after cardiac arrest.
There were 508 individuals who were discharged alive from hospitals in King County, Washington; 373 (73%) were interviewed by telephone 123±43 days after the initial event. Overall, 59% of the treatment group and 58% of the control group had Cerebral Performance Category (CPC) 1 or 2 (P=0.70), and 50% of the treatment group and 49% of the control group had slight disability or better by the Modified Rankin Scale (MRS; (P=0.35). One-year survival was 87% in the treatment group and 84% in the control group (P=0.42). Of those with CPC 1 at hospital discharge, 68% had CPC 1 or 2 at follow-up, and 59% had MRS of slight disability or better. Of 41 patients with CPC 3 or 4 at discharge, only 12% had CPC 2 at follow-up, and just 5% had MRS of slight disability or better. One-year survival was 92% for CPC 1 at discharge, but only 40% for CPC 4.
In addition to excellent survival, patients who had good neurological function at discharge continued to have good function at least 3 months after the event.
URL: Clinicaltrials.gov. Unique identifier: NCT00391469.
心脏骤停后院前降温的随机试验表明,院前降温和目标温度管理均未对短期生存或神经功能产生差异影响。在这项随访研究中,我们评估了心脏骤停后至少3个月的院前低温与神经功能以及心脏骤停后1年生存率之间的关联。
华盛顿州金县有508例患者从医院存活出院;在初始事件发生123±43天后,对其中373例(73%)进行了电话访谈。总体而言,治疗组59%和对照组58%的患者脑功能分类(CPC)为1或2(P = 0.70),治疗组50%和对照组49%的患者根据改良Rankin量表(MRS)评定为轻度残疾或更好(P = 0.35)。治疗组1年生存率为87%,对照组为84%(P = 0.42)。出院时CPC为1的患者中,68%在随访时CPC为1或2,59%的患者MRS为轻度残疾或更好。出院时CPC为3或4的41例患者中,随访时只有12%的患者CPC为2,仅有5%的患者MRS为轻度残疾或更好。出院时CPC为1的患者1年生存率为92%,但CPC为4的患者仅为40%。
除了具有出色的生存率外,出院时神经功能良好的患者在事件发生后至少3个月仍保持良好功能。
网址:Clinicaltrials.gov。唯一标识符:NCT00391469。